Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Grant or award EVP and Chief Medical Officer acquired 4,658 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Returned to the company SVP, Chief Accounting Officer returned 181 shares (to the company)
  4. 4 Open-market sale EVP and Chief Medical Officer sold 3,881 shares at $45.25 ($175,615)
  5. 4 Open-market sale EVP and Chief Legal Officer sold 3,161 shares at $45.25 ($143,035)
  6. 4 Open-market sale CBO & EVP sold 1,968 shares at $45.27 ($89,091)
  7. 4 Open-market sale SVP, Chief Accounting Officer sold 100 shares at $45.65 ($4,565)
  8. 4 Open-market sale Huang Dennis Karl sold 389 shares at $45.65 ($17,758)
  9. 4 Open-market sale Pinion John Richard sold 3,755 shares at $45.26 ($169,951)
  10. 4 Shares withheld for taxes President & CEO gave up 16,140 shares (to pay taxes)
  11. 4 Open-market sale EVP & Chief Commercial Officer sold 3,664 shares at $45.25 ($165,796)
  12. 4 Open-market sale SVP, Chief Accounting Officer sold 639 shares at $43.40 ($27,733)
  13. 4 Open-market sale President & CEO sold 19,582 shares at $45.57 ($892,352)
  14. 4 Open-market sale SVP, Chief Accounting Officer sold 2,031 shares at $43.96 ($89,283)
  15. 4 Open-market sale CFO & Executive Vice President sold 1,629 shares at $40.16 ($65,421)
  16. 4 Open-market sale CFO & Executive Vice President sold 3,484 shares at $38.22 ($133,158)
  17. 4 Grant or award CFO & Executive Vice President acquired 20,000 shares (grant or award)
  18. 4 Grant or award SVP, Chief Accounting Officer acquired 1,000 shares (grant or award)
  19. 4 Grant or award Director acquired 3,300 shares (grant or award)
  20. 4 Grant or award Director acquired 3,300 shares (grant or award)

Page 7 of 32 · 627 filings